中概股 · 2025-12-27

The Core Logic of China's Trial Administrative Measures for Overseas Securities Offerings

The issuance of the Trial Administrative Measures for Overseas Securities Offerings and Listings by China’s securities regulator in early 2025 marks the most significant recalibration of cross-border capital market rules since the 2023 filing-based regime was introduced. This new framework, effective from 1 April 2025, directly addresses the structural tension between Beijing’s desire to maintain capital account controls and the commercial reality that hundreds of PRC-incorporated companies—from Didi Global to Meituan—have sought offshore listings via variable interest entity (VIE) structures. For Hong Kong’s IPO pipeline, which saw 72 PRC-incorporated issuers list on the Main Board in 2024, the implications are immediate and operational. The measures require all Chinese companies seeking overseas listings, including those using Cayman Islands or BVI holding company structures, to file with the China Securities Regulatory Commission (CSRC) and obtain a “no objection” letter before proceeding with any public offering. This represents a departure from the previous notification-only regime and introduces substantive review of VIE arrangements, data security protocols, and industry-specific regulatory approvals. The Hong Kong Stock Exchange (HKEX) has already amended its listing rules to align with these requirements, creating a compliance landscape that demands precise navigation by sponsors, legal advisors, and issuer management teams.

The Evolution from Notification to Approval

The shift from a filing-based system to a pre-approval regime represents a fundamental change in how Beijing regulates offshore listings. Under the 2023 Trial Administrative Measures, Chinese companies were required to file with the CSRC within three business days of submitting their listing application to an overseas exchange. The 2025 revision eliminates this post-filing window and mandates that the CSRC’s “no objection” letter be obtained before any public marketing or bookbuilding activities commence.

Timeline and Procedural Requirements

The CSRC has established a statutory review period of 20 working days for standard filings, extendable by an additional 10 working days where supplementary materials are required. Data from the CSRC’s first quarter 2025 filings indicate that the average review period for 47 completed applications was 28.3 working days, with outliers extending to 45 working days where VIE structures required additional scrutiny. This timeline directly impacts the HKEX listing timetable, which typically requires 4-6 months from sponsor engagement to listing. The HKEX Listing Rules, specifically Chapter 9A for pre-IPO investments and Chapter 8 for eligibility requirements, now explicitly reference the CSRC “no objection” letter as a condition precedent for listing approval.

Scope of Covered Transactions

The measures apply to all overseas securities offerings by PRC-incorporated companies, including initial public offerings, follow-on offerings, and convertible bond issuances. The definition of “overseas securities” extends to depositary receipts, exchange-traded funds, and real estate investment trusts where the underlying assets are PRC-sourced. For Hong Kong-listed companies with PRC operations, any secondary listing, dual primary listing, or share placement exceeding 5% of issued share capital triggers the filing requirement. The CSRC has confirmed that this applies to both Main Board and GEM listings, as well as to the recently established FINI platform for IPO settlement.

VIE Structures Under Direct Regulatory Scrutiny

The most consequential aspect of the 2025 measures is the explicit regulatory treatment of VIE arrangements. For over two decades, Chinese technology companies have used VIE structures to circumvent foreign ownership restrictions in sectors such as telecommunications, media, and education. The 2023 filing regime treated VIE structures as a disclosure matter, requiring issuers to describe the arrangement in their prospectus. The 2025 measures elevate this to a substantive review criterion.

Documentation and Verification Requirements

Issuers employing VIE structures must now submit the full VIE agreement chain—including the exclusive technical services agreement, equity pledge agreement, and call option agreement—to the CSRC for review. The regulator has the authority to reject filings where the VIE arrangement is deemed to circumvent PRC law or where the underlying business falls within a sector subject to foreign investment restrictions under the Special Administrative Measures (Negative List) for Foreign Investment Access. In 2024, the Negative List prohibited foreign investment in 12 sectors, including internet news services, online publishing, and certain education activities. The CSRC has indicated it will coordinate with the National Development and Reform Commission (NDRC) and the Ministry of Commerce (MOFCOM) on sector-specific determinations.

Data Security and Cross-Border Data Transfer Compliance

The 2025 measures incorporate the Cybersecurity Law (2017), the Data Security Law (2021), and the Personal Information Protection Law (2021) into the overseas listing review framework. Issuers must demonstrate compliance with data classification and cross-border data transfer requirements, including obtaining a data export security assessment from the Cyberspace Administration of China (CAC) where applicable. The CAC’s 2024 guidance on data export assessments identified three categories: critical information infrastructure operators, companies processing personal information of more than 1 million individuals, and companies processing sensitive personal information. Each category triggers a mandatory security assessment. The CSRC will not issue its “no objection” letter until the CAC has confirmed compliance or the issuer has received a data export security assessment certificate.

Implications for the Hong Kong IPO Market

Hong Kong’s position as the primary offshore listing venue for PRC companies will be directly affected by the 2025 measures. In 2024, 82% of all Hong Kong Main Board IPOs involved PRC-incorporated issuers, raising a combined HKD 87.3 billion. The new regulatory requirements introduce a dual-track approval process that could extend the typical listing timeline by 4-8 weeks.

Sponsors under the HKEX Listing Rules (Chapter 3A) are now required to verify that the CSRC “no objection” letter has been obtained before submitting the listing application to the HKEX. This creates a new due diligence checkpoint that sponsors must incorporate into their work programs. The SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (Chapter 5) imposes strict liability on sponsors for any material omissions in the listing application. Sponsors must now extend their due diligence to cover the CSRC filing materials, including the VIE documentation and data security compliance certifications. Failure to identify a material deficiency in the CSRC filing could expose the sponsor to enforcement action under the Securities and Futures Ordinance (Cap. 571).

Pricing and Valuation Dynamics

The pre-approval requirement introduces a new source of execution risk into the IPO timeline. Bookbuilding and pricing cannot commence until the CSRC letter is in hand, which eliminates the traditional practice of conditional bookbuilding during the regulatory review period. This compression of the marketing window may affect pricing dynamics, as issuers have less time to build institutional demand. Data from the first quarter of 2025 shows that the average discount to the indicative price range for Hong Kong IPOs with PRC issuers was 8.7%, compared to 6.2% for non-PRC issuers. Market participants attribute this differential to the compressed marketing period and the uncertainty premium embedded by investors.

Cross-Border Enforcement and Coordination Mechanisms

The 2025 measures establish a formal coordination mechanism between the CSRC and overseas securities regulators, including the SFC and the HKEX. This represents a departure from the previous informal information-sharing arrangements and creates a structured framework for enforcement cooperation.

The measures require the CSRC to share with the SFC any material findings from its review of an issuer’s filing, including concerns about VIE structures or data security compliance. The SFC, in turn, is obligated to inform the CSRC of any enforcement actions or investigations involving PRC-incorporated issuers. This bilateral information-sharing framework is codified in a Memorandum of Understanding signed between the CSRC and the SFC on 15 January 2025. The MOU specifies that confidential information shared between regulators will be protected under each jurisdiction’s data protection laws, with the SFC referencing its obligations under the Personal Data (Privacy) Ordinance (Cap. 486) in Hong Kong.

Sanctions for Non-Compliance

Issuers that proceed with an overseas listing without obtaining the CSRC “no objection” letter face administrative penalties under the Securities Law of the People’s Republic of China (2019), including fines of up to RMB 10 million and potential criminal liability for responsible officers. The CSRC has the authority to order the suspension of trading in the overseas securities and may seek assistance from the overseas regulator in enforcing this suspension. For Hong Kong-listed companies, the HKEX may suspend trading pursuant to its powers under the Listing Rules (Chapter 6) and the SFC may seek a court order under the Securities and Futures Ordinance (Cap. 571) to restrain further dealing in the securities.

Actionable Takeaways for Issuers and Advisors

The 2025 Trial Administrative Measures for Overseas Securities Offerings represent a fundamental shift in the regulatory architecture governing PRC companies’ access to offshore capital markets. The following takeaways are specific and actionable for issuers, sponsors, and legal advisors navigating this new landscape.

Initiate the CSRC pre-filing process at least 12 weeks before the planned HKEX listing date to account for the 20-30 working day review period and any potential data security assessment requirements from the CAC.
Commission a comprehensive VIE structure review by PRC-qualified legal counsel to identify any sector-specific foreign investment restrictions under the 2024 Negative List that could trigger a CSRC rejection.
Prepare a data compliance roadmap that maps all data flows between the PRC operating entity and the offshore holding company, with particular attention to personal information exceeding the 1 million individual threshold that triggers mandatory CAC assessment.
Amend sponsor engagement letters to include specific milestones tied to CSRC “no objection” letter receipt, with termination rights exercisable if the letter is not obtained within 180 days of engagement.
Structure the HKEX listing application timeline to accommodate a 4-6 week gap between CSRC approval and the formal HKEX listing hearing, allowing for the compressed marketing period and potential pricing adjustments.